Extension of life-span by introduction of telomerase into normal human cells.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory experiment using cultured human cell lines (bench research).
PubMed 9454332 · doi:10.1126/science.279.5349.349
What was done
Two telomerase-negative normal human cell types (retinal pigment epithelial cells and foreskin fibroblasts) were transfected with vectors encoding the human telomerase catalytic subunit to test whether telomere maintenance prevents cellular senescence. Transfected clones were evaluated for telomere length, proliferative capacity, senescence biomarker staining (beta-galactosidase), and karyotype stability compared to telomerase-negative control clones.
What was found
Telomerase-negative control clones underwent telomere shortening and entered replicative senescence. Telomerase-expressing clones exhibited elongated telomeres, divided vigorously, showed reduced staining for beta-galactosidase, maintained a normal karyotype, and exceeded their normal lifespan by at least 20 doublings. Specific baseline lifespan numbers, exact cell counts, and telomere lengths were not reported in the abstract.
Why it matters
This study provided direct experimental evidence that telomere shortening causes replicative senescence in cultured human cells, demonstrating that telomerase activation can overcome cellular senescence without immediate chromosomal instability.
Limits
The findings are derived entirely from in vitro cell cultures across only two cell types and do not directly evaluate organismal aging, tissue homeostasis in vivo, or long-term oncogenic risks beyond basic karyotype observation.
Cited by
- supports Telomerase is an intracellular RNA reverse transcriptase that rebuilds telomeres, and knocking it down stops cell division while upregulating it immortalizes cells.